A common variant in methionine synthase reductase combined with low cobalamin (Vitamin B12) increases risk for spina bifida

Molecular Genetics and Metabolism

Volumn 67, Issue 4, 1999, Pages 317-323

  Wilson, Aaron ^a,b   Platt, Robert ^a,b   Wu, Qing ^a   Leclerc, Daniel ^a   Christensen, Benedicte ^c   Yang, Hong ^a   Gravel, Roy A ^a,b   Rozen, Rima ^a,b  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NONE

Author keywords

Methionine synthase reductase; Polymorphism; Spina bifida

Indexed keywords

CYANOCOBALAMIN; METHIONINE SYNTHASE; OXIDOREDUCTASE;

ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RISK FACTOR; SPINA BIFIDA;

TRIXIS;

EID: 0032856882     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2879     Document Type: Article

References (24)

1. Czeizel A, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med. 327:1992;1832-1835.
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet. 338:1991;131-137.
3. 12) in amniotic fluid. Am J Hum Genet. 61:1997;4.
4. 12 are independent risk factors for neural tube defects. Q J Med. 86:1993;703-708.
5. Adams M J Jr, Khoury M J, Scanlon K S, Stevenson R E, Knight G J, Haddow J E, Syvester G C, Cheek J E, Henry J P, Stabler S P, Allen R H. Elevated midtrimester serum methymalonic acid levels as a risk factor for neural tube defects. Teratology. 51:1995;311-317.
6. Frosst P, Blom H J, Milos R, Goyette P, Sheppard C A, Matthews R G, Boers G JH, den Heijer M, Kluijtmans L AS, van den Heuvel L P, Rozen R. A candidate risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet. 10:1995;111-113.
7. van der Put N MJ, Steegers-Theunissen R, Frosst P, Trijbels F JM, Eskes T KAB, van der Heuvel L P, Mariman E CM, den Heyer M, Rozen R, Blom H J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1995;1070-1071.
8. Whitehead A S, Gallagher P, Mills J L, Kirke P N, Burke H, Molloy A M, Weir D G, Sheilds D C, Scott J M. A genetic defect in 5, 10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med. 88:1995;763-766.
9. Ou C Y, Stevenson R E, Brown V K, Schwarz C E, Allen W P, Khoury M J, Rozen R, Oakley G P Jr, Adams M J Jr. 5,10-Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet. 63:1996;610-614.
10. Jacques P F, Bostom A G, Williams R R, Ellison R C, Eckfeldt J H, Rosenberg I H, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:1996;7-9.
11. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt D S, Genest J Jr, Rozen R. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Atheroscler Thromb Vascular Biol. 17:1997;569-573.
12. Leclerc D, Campeau E, Goyette P, Adjalla C E, Christensen B, Ross M, Eydoux P, Rosenblatt D S, Rosen R, Gravel R A. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Molec Genet. 5:1996;1867-1874.
13. Chen L H, Liu M L, Hwang H Y, Chen L S, Korenberg J, Shane B. Human methionine synthase cDNA cloning, gene localization and expression. J Biol Chem. 272:1997;3628-3634.
14. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix B M, Rosenblatt D S, Gravel R A, Forbes P, Rozen R. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet. 84:1999;151-157.
15. van der Put N MJ, van der Molen E F, Kluijtmans L AJ, Heil S G, Trijbels J MF, Eskes T KAB, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom H J. Sequence analysis of the coding region of methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Q J Med. 90:1997;511-517.
16. Morrison E, Edwards Y H, Lynch S A, Burn H, Hol F, Mariman E. Methionine synthase and neural tube defects. J Med Genet. 34:1997;958-960.
17. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng H HQ, Rommens J M, Scherer S W, Rosenblatt D S, Gravel R A. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA. 95:1998;3059-3064.
18. Watkins D, Rosenblatt D S. Functional methionine synthase deficiency (cblE and cblG): Clinical and biochemical heterogeneity. Am J Med Genet. 34:1989;427-434.
19. van der Put N MJ, van den Heuvel L P, Steegers-Theunissen R PM, Trijbels F JM, Eskes T KAB, Mariman E CM, Den Heyer M, Blom H J. Decreased methylenetetrahydrofolate reductase activity due to the 677C→T mutation in families with spina bifida offspring. J Mol Med. 74:1996;691-694.
20. Magnus P, Magnus E M, Berg K. Increased levels of apo-transcobalamins I and II in amniotic fluid from pregnant women with previous neural tube defect children. Clin Genet. 30:1986;167-172.
21. Rosenquist T H, Ratashak S A, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid. Proc Natl Acad Sci USA. 93:1996;15227-15232.
22. Steegers-Theunissen R PM, Boers G HJ, Trijbels F JM, Finkelstein J D, Blom H J, Thomas C MG, Borm G F, Wouters M GAJ, Eskes T KAB. Maternal hyperhomocysteinemia: A risk factor for neural tube defects? Met Clin Exp. 43:1994;1475-1480.
23. Mills J L, McPartlin J M, Kirke P N, Lee Y J, Conley M R, Weir D G, Scott J H. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 345:1995;149-151.
24. Motulsky, A, G. Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet58:17-20, 1996.